EPO Patents = 3

Forward Citations = 6

Loading Chart...

22 inventors (with patents filed for the assignee):

Martijn Antonius Johannes Cox (3 out of 14 patents)

Tom Lavrijsen (3 out of 5 patents)

Clemens Antoni Van Blitterswijk (2 out of 8 patents)

4. Joris Ivo Rotmans (2 out of 3 patents)

5. Tonia Caroline Rothuizen (2 out of 2 patents)

6. Lorenzo Moroni (2 out of 2 patents)

7. Febriyani Fiain Rochel Damanik (2 out of 2 patents)

8. Antonius Johannes Rabelink (2 out of 2 patents)

9. Henricus Marie Janssen (2 out of 20 patents)

10. Tristan Mes (1 out of 8 patents)

11. Anton Willem Bosman (1 out of 23 patents)

12. Anandkumar Nandakumar (1 out of 4 patents)

13. Franciscus Petrus Thomas Baaijens (1 out of 12 patents)

14. Patricia Yvonne Wilhelmina Dankers (1 out of 8 patents)

15. Carolina Victoria Catharina Bouten (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 10933163 - In situ tissue engineering (2021-03-02),

2. 10232081 - In situ tissue engineering (2019-03-19),

3. 9877852 - Implant (2018-01-30),

4. 9220809 - Use of a fluorinated polymer as a contrast agent in solid state 19F magnetic resonance imaging (MRI), scaffold comprising said polymer and use thereof (2015-12-29),

Xeltis is a global medical technology company focused on transforming standards of care in heart valve technology. The company is pioneering a restorative approach to cardiovascular treatment, developing bioabsorbable heart valves that allow the body to create its own natural tissue. Xeltis is committed to improving patient outcomes and quality of life through innovative medical solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#76 in Eindhoven

#1,303 in Netherlands

Eindhoven, Netherlands

Xeltis B.v.